Predictors of 90-Day Mortality following Hepatic Resection for Hepatocellular Carcinoma
- PMID: 33981750
- PMCID: PMC8077452
- DOI: 10.1159/000510811
Predictors of 90-Day Mortality following Hepatic Resection for Hepatocellular Carcinoma
Abstract
Background/purpose: 90-day mortality is a key performance indicator for short-term perioperative outcome of hepatic resection (HR). Although many preoperative, intraoperative, and postoperative variables predict 90-day mortality following elective HR, only few are specific to hepatocellular carcinoma (HCC). This study aims to determine the predictors of 90-day mortality following elective HR for HCC.
Methods: We report a retrospective analysis of patients who underwent elective HR between January 1, 2007, and December 31, 2017. Health status, perioperative variables, and the presence of post-hepatectomy liver failure (PHLF) were studied. Cox's regression evaluated factors predicting 90-day mortality.
Results: Two hundred and forty-four patients diagnosed with HCC underwent HR; 102 (41.8%) underwent a major HR. The postoperative 90-day mortality rate was 5.3%. Multivariate analysis demonstrated that Child-Pugh score (p < 0.001), intraoperative blood loss (p = 0.013), the 50-50 criteria for PHLF (p < 0.001) on postoperative day 5, and peak serum bilirubin >119 µmol/L (p = 0.007) on postoperative day 3 predict 90-day mortality.
Conclusion: In patients with HCC undergoing HR, Child-Pugh score, intraoperative blood loss, the 50-50 criteria for PHLF on postoperative day 5, and peak serum bilirubin >119 µmol/L on postoperative day 3 predict 90-day mortality following elective HR for HCC.
Keywords: Hepatic resection; Hepatocellular carcinoma.
Copyright © 2020 by S. Karger AG, Basel.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Predictors of mortality within the first year post-hepatectomy for hepatocellular carcinoma.J Egypt Natl Canc Inst. 2022 Apr 4;34(1):14. doi: 10.1186/s43046-022-00113-8. J Egypt Natl Canc Inst. 2022. PMID: 35368234
-
A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma.Clin Res Hepatol Gastroenterol. 2021 Jul;45(4):101534. doi: 10.1016/j.clinre.2020.09.001. Epub 2020 Oct 13. Clin Res Hepatol Gastroenterol. 2021. PMID: 33067168
-
A Comparative Study of Albumin-Bilirubin Score with Child-Pugh Score, Model for End-Stage Liver Disease Score and Indocyanine Green R15 in Predicting Posthepatectomy Liver Failure for Hepatocellular Carcinoma Patients.Dig Dis. 2018;36(3):236-243. doi: 10.1159/000486590. Epub 2018 Mar 1. Dig Dis. 2018. PMID: 29495004
-
Clearance of the liver remnant predicts short-term outcome in patients undergoing resection of hepatocellular carcinoma.World J Gastroenterol. 2022 Oct 14;28(38):5614-5625. doi: 10.3748/wjg.v28.i38.5614. World J Gastroenterol. 2022. PMID: 36304091 Free PMC article. Review.
-
Predicting Post-Hepatectomy Liver Failure in HCC Patients: A Review of Liver Function Assessment Based on Laboratory Tests Scores.Medicina (Kaunas). 2023 Jun 7;59(6):1099. doi: 10.3390/medicina59061099. Medicina (Kaunas). 2023. PMID: 37374303 Free PMC article. Review.
Cited by
-
A combined pre- and intra-operative nomogram in evaluation of degrees of liver cirrhosis predicts post-hepatectomy liver failure: a multicenter prospective study.Hepatobiliary Surg Nutr. 2024 Apr 3;13(2):198-213. doi: 10.21037/hbsn-22-410. Epub 2023 Mar 15. Hepatobiliary Surg Nutr. 2024. PMID: 38617471 Free PMC article.
-
Outcomes of liver resection in hepatitis C virus-related intrahepatic cholangiocarcinoma: A systematic review and meta-analysis.World J Virol. 2024 Mar 25;13(1):88946. doi: 10.5501/wjv.v13.i1.88946. World J Virol. 2024. PMID: 38616852 Free PMC article.
-
A Comparison of Adverse Events Among Radiofrequency Ablation, Conventional Transarterial Chemoembolization (TACE) and Drug-Eluting Bead TACE in Treating Hepatocellular Carcinoma Patients.Cancer Manag Res. 2021 Jul 5;13:5373-5382. doi: 10.2147/CMAR.S308097. eCollection 2021. Cancer Manag Res. 2021. PMID: 34262345 Free PMC article.
-
Effect of ABO blood group on postoperative overall survival and recurrence-free survival rate in patients with hepatocellular carcinoma after hepatectomy: a multi-center retrospective cohort study.BMC Surg. 2023 Oct 24;23(1):324. doi: 10.1186/s12893-023-02236-8. BMC Surg. 2023. PMID: 37875876 Free PMC article.
-
Previous nonhepatectomy abdominal surgery did not increase the difficulty in laparoscopic hepatectomy for hepatocellular carcinoma: A case-control study in 100 consecutive patients.Tzu Chi Med J. 2023 Feb 13;35(3):247-252. doi: 10.4103/tcmj.tcmj_293_22. eCollection 2023 Jul-Sep. Tzu Chi Med J. 2023. PMID: 37545796 Free PMC article.
References
-
- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar;136((5)):E359–86. - PubMed
-
- Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, Global Burden of Disease Liver Cancer Collaboration et al. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. JAMA Oncol. 2017 Dec;3((12)):1683–91. - PMC - PubMed
-
- Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Panel of Experts in HCC-Design Clinical Trials et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst. 2008 May;100((10)):698–711. - PubMed
-
- Yamaguchi SK, Eguchi S. Hepatic resection for hepatocellular carcinoma. Hepatoma Res. 2018;4((8)):50.
-
- Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg. 2007 May;204((5)):854–62. - PubMed
LinkOut - more resources
Full Text Sources